HCP2303

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HCP2303, covering 2024-07-16 to 2024-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers [Phase 1]

See pricing